IDiyas

For the Inventor, By the Inventor

Stevenage, United Kingdom

Richard Lewis Jarvest

USPTO Granted Patents = 19

Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 94(Granted Patents)


Location History:

  • Epsom, GB (1990)
  • Ware, GB (2001 - 2002)
  • Surbiton, GB (1991 - 2003)
  • Harlow, GB (2005 - 2007)
  • Stevenage, GB (2005 - 2009)

Company Filing History:

goldMedal6 out of 2,198 
 
Smithkline Beecham Corporation
 patents
silverMedal5 out of 855 
 
Beecham Group Plc
 patents
bronzeMedal3 out of 12 
 
Replidyne, Inc.
 patents
4. 3 out of 29 
 
Novartis International Pharmaceutical, Ltd.
 patents
5. 2 out of 1,168 
 
Glaxo Group Limited
 patents
6. 1 out of 2 
 
Pliva-istrazivacki Institut
 patents
where one patent can have more than one assignee

Years Active: 1990-2009

Loading Chart...
19 patents (USPTO):
1. 7569550 - 14 and 15 membered ring compounds (2009-08-04),
2. 7351696 - Compounds (2008-04-01),
3. 7220757 - Compositions and methods for topical administration of 2-NH-heteroarylimidazoles (2007-05-22),
4. 7160907 - Pleuromutilin derivatives (2007-01-09),
5. 7030137 - Substituted thiophenes with antibacterial activity (2006-04-18),
6. 6943175 - 2-NH-heteroarylimidazoles with antibacterial activity (2005-09-13),
7. 6900345 - Pleuromutilin derivatives (2005-05-31),
8. 6579981 - Antiviral guanine derivatives (2003-06-17),
9. 6573378 - Antiviral guanine derivatives (2003-06-03),
10. 6388074 - Process for the preparation of purine derivatives (2002-05-14),
11. 6320051 - Quinolones used as MRS inhibitors and bactericides (2001-11-20),
12. 6187922 - Process for the preparation of purine derivatives (2001-02-13),
13. 5886215 - 2-acetoxymethyl-4-halo-butyl-1-yl acetates (1999-03-23),
14. 5684153 - Process for the preparation of purine derivatives (1997-11-04),
15. 5519006 - Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or (1996-05-21),

Title: Richard Lewis Jarvest: Pioneering Innovator in Pharmaceutical Compounds

Introduction:

Richard Lewis Jarvest, a visionary inventor hailing from Stevenage, GB, has left an indelible mark on the field of pharmaceutical compounds with his relentless passion for innovation and pursuit of excellence.

Latest Patents:

Jarvest's latest patents include groundbreaking discoveries in the realm of pharmaceutical compounds. His inventions focus on 14- or 15-membered macrolides substituted at the 4″ position and various other compounds aimed at addressing systemic or topical microbial infections in human or animal bodies.

Career Highlights:

With an impressive portfolio of 19 patents to his name, Jarvest has made significant contributions to the medical field. His work has revolutionized the way microbial infections are treated and prevented, showcasing his dedication to advancing healthcare through inventive solutions.

Collaborations:

Throughout his career, Jarvest has collaborated with esteemed companies such as SmithKline Beecham Corporation and Beecham Group Plc. Working alongside individuals like Michael R Harnden and John Michael Berge, he has synergized his innovative prowess with the expertise of his coworkers to drive impactful advancements in pharmaceutical research.

Conclusion:

Richard Lewis Jarvest's unwavering commitment to pushing the boundaries of innovation in pharmaceutical compounds has established him as a pioneering figure in the field. His revolutionary patents and collaborative efforts stand as a testament to his visionary spirit and enduring impact on the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…